Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1
- PMID: 20479210
- PMCID: PMC2876408
- DOI: 10.1128/AAC.00892-09
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 1
Comment on
-
Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.Antimicrob Agents Chemother. 2009 Jul;53(7):2887-91. doi: 10.1128/AAC.01430-08. Epub 2009 Apr 13. Antimicrob Agents Chemother. 2009. PMID: 19364846 Free PMC article.
Similar articles
-
Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity. Comment letter 2.Antimicrob Agents Chemother. 2010 Jun;54(6):2750-1; author reply 2752. Antimicrob Agents Chemother. 2010. PMID: 20480959 No abstract available.
-
Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.Antimicrob Agents Chemother. 2009 Jul;53(7):2887-91. doi: 10.1128/AAC.01430-08. Epub 2009 Apr 13. Antimicrob Agents Chemother. 2009. PMID: 19364846 Free PMC article.
-
[Ototoxicity and nephrotoxicity of netilmicin and other aminoglycoside antibiotics in rabbits].Nihon Jibiinkoka Gakkai Kaiho. 1982 Apr 20;85(4):447-54. Nihon Jibiinkoka Gakkai Kaiho. 1982. PMID: 7119929 Japanese. No abstract available.
-
Aminoglycoside-induced nephrotoxicity.J Pharm Pract. 2014 Dec;27(6):573-7. doi: 10.1177/0897190014546836. Epub 2014 Sep 7. J Pharm Pract. 2014. PMID: 25199523 Review.
-
[Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].Minerva Med. 1978 Dec 15;69(61):4215-25. Minerva Med. 1978. PMID: 366465 Review. Italian. No abstract available.
Cited by
-
Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients.Int J Crit Illn Inj Sci. 2011 Jan;1(1):17-21. doi: 10.4103/2229-5151.79277. Int J Crit Illn Inj Sci. 2011. PMID: 22096769 Free PMC article.
-
Efficacy and Safety of Plazomicin in the Treatment of Enterobacterales Infections: A Meta-analysis of Randomized Controlled Trials.Open Forum Infect Dis. 2022 Aug 29;9(9):ofac429. doi: 10.1093/ofid/ofac429. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36092826 Free PMC article. Review.
References
-
- Beardsley, J. R., J. C. Williamson, J. W. Johnson, C. A. Ohl, T. B. Karchmer, and D. L. Bowton. 2006. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130:787-793. - PubMed
-
- Bhat, S., S. Fujitani, B. A. Potoski, B. Capitano, P. K. Linden, K. Shutt, and D. L. Paterson. 2007. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Int. J. Antimicrob. Agents 30:458-462. - PubMed
-
- Drusano, G. L., P. G. Ambrose, S. M. Bhavnani, J. S. Bertino, A. N. Nafziger, and A. Louie. 2007. Back to the future: using aminoglycosides again and how to dose them optimally. Clin. Infect. Dis. 45:753-760. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical